A detailed history of Northern Trust Corp transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 314,529 shares of TMDX stock, worth $27.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
314,529
Previous 279,898 12.37%
Holding current value
$27.8 Million
Previous $42.2 Million 17.13%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$135.68 - $176.11 $4.7 Million - $6.1 Million
34,631 Added 12.37%
314,529 $49.4 Million
Q2 2024

Aug 14, 2024

SELL
$72.62 - $150.62 $623,660 - $1.29 Million
-8,588 Reduced 2.98%
279,898 $42.2 Million
Q1 2024

May 14, 2024

SELL
$70.86 - $89.93 $571,485 - $725,285
-8,065 Reduced 2.72%
288,486 $21.3 Million
Q4 2023

Feb 13, 2024

SELL
$36.74 - $81.08 $1.49 Million - $3.3 Million
-40,680 Reduced 12.06%
296,551 $23.4 Million
Q3 2023

Nov 13, 2023

BUY
$53.47 - $96.07 $178,857 - $321,354
3,345 Added 1.0%
337,231 $18.5 Million
Q2 2023

Aug 11, 2023

BUY
$66.23 - $88.73 $1.11 Million - $1.48 Million
16,692 Added 5.26%
333,886 $28 Million
Q1 2023

May 15, 2023

BUY
$53.63 - $82.33 $298,129 - $457,672
5,559 Added 1.78%
317,194 $24 Million
Q4 2022

Feb 13, 2023

BUY
$39.08 - $64.29 $197,940 - $325,628
5,065 Added 1.65%
311,635 $19.2 Million
Q3 2022

Nov 14, 2022

BUY
$31.56 - $55.75 $904,730 - $1.6 Million
28,667 Added 10.32%
306,570 $12.8 Million
Q2 2022

Aug 12, 2022

BUY
$20.56 - $32.15 $71,877 - $112,396
3,496 Added 1.27%
277,903 $8.74 Million
Q1 2022

May 13, 2022

SELL
$12.58 - $26.94 $131,247 - $281,065
-10,433 Reduced 3.66%
274,407 $7.39 Million
Q4 2021

Feb 08, 2022

SELL
$19.16 - $32.68 $42,803 - $73,007
-2,234 Reduced 0.78%
284,840 $5.46 Million
Q3 2021

Nov 15, 2021

SELL
$25.92 - $34.51 $269,645 - $359,007
-10,403 Reduced 3.5%
287,074 $9.5 Million
Q2 2021

Aug 13, 2021

BUY
$21.63 - $40.07 $232,068 - $429,911
10,729 Added 3.74%
297,477 $9.87 Million
Q1 2021

May 12, 2021

SELL
$17.75 - $47.82 $637,509 - $1.72 Million
-35,916 Reduced 11.13%
286,748 $11.9 Million
Q4 2020

Feb 11, 2021

SELL
$11.91 - $19.9 $155,675 - $260,112
-13,071 Reduced 3.89%
322,664 $6.42 Million
Q3 2020

Nov 16, 2020

BUY
$13.78 - $18.84 $949,993 - $1.3 Million
68,940 Added 25.84%
335,735 $4.63 Million
Q2 2020

Aug 14, 2020

BUY
$11.66 - $18.26 $1.14 Million - $1.79 Million
97,856 Added 57.92%
266,795 $4.78 Million
Q1 2020

May 14, 2020

SELL
$10.5 - $20.2 $16,579 - $31,895
-1,579 Reduced 0.93%
168,939 $2.04 Million
Q4 2019

Feb 14, 2020

BUY
$16.61 - $21.64 $1.21 Million - $1.58 Million
72,913 Added 74.7%
170,518 $3.24 Million
Q3 2019

Nov 13, 2019

BUY
$20.27 - $28.93 $1.24 Million - $1.77 Million
61,333 Added 169.09%
97,605 $2.32 Million
Q2 2019

Aug 13, 2019

BUY
$22.36 - $30.41 $811,041 - $1.1 Million
36,272 New
36,272 $1.05 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.81B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.